[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Wednesday, 7 February 2007, 12:54 GMT
Tamiflu boosts drug firm's profit
Masked person holding Tamiflu pills
Many countries have been stockpiling Roche's Tamiflu drug
Swiss drugs group Roche has reported a 34% jump in annual profits, boosted by sales of its flu anti-viral Tamiflu.

Roche said net income in 2006 rose to 9.17bn Swiss francs (3.7bn; $7.4bn), from 6.86bn francs a year ago.

The Basel-based firm added that strong demand for its cancer drugs Herceptin and Avastin also buoyed profits.

However Roche said it expected demand for Tamiflu from governments building stockpiles to slip in 2007, despite a recent outbreak of bird flu in the UK.

Roche said total group sales during 2006 rose by 17% to 42bn francs.

The company added that it expected further strong growth in 2007, driven by its pharmaceuticals and diagnostics divisions.

"With our broad portfolio of innovative products and strong R&D pipeline, we are equipped to continue growing well ahead of the market," said chairman Franz Humer.


SEE ALSO
Tamiflu-maker sees strong sales
26 Apr 06 |  Business
Roche dips on bird flu drug claim
22 Dec 05 |  Business
US clears bird flu drug Tamiflu
19 Nov 05 |  Health
Tamiflu firms in licensing deal
16 Nov 05 |  Business

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites



FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

PRODUCTS & SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific